[Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy].

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Der Internist

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 14735240
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mitochondrial antigen/antibody systems in primary biliary cirrhosis: revisited.

  2008cited by this paper
• Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis.

  2008cited by this paper
• Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis.

  2003cited by this paper
• Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: An observational study

  2003cited by this paper
• Methotrexate Therapy for Primary Biliary Cirrhosis

  2003cited by this paper
• Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosis.

  2003cited by this paper
• Drug hepatotoxicity.

  2002cited by this paper
• Osteoporosis is not a specific complication of primary biliary cirrhosis (PBC)

  2002cited by this paper
• Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited

  2002cited by this paper
• Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions.

  2002cited by this paper
• Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis

  2002cited by this paper
• The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study

  2002cited by this paper
• Autoimmune hepatitis and overlap syndromes

  2002cited by this paper
• Autoimmune hepatitis: clinical challenges.

  2001cited by this paper
• Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center

  2001cited by this paper
• Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis.

  2001cited by this paper
• Recurrent primary biliary cirrhosis.

  2000cited by this paper
• Autoimmunity in liver diseases

  2000cited by this paper
• Autoimmune tests in primary biliary cirrhosis.

  2000cited by this paper
• Pruritus and fatigue in primary biliary cirrhosis.

  2000cited by this paper
• Evidence-based therapy of primary biliary cirrhosis.

  1999cited by this paper
• Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?

  1999cited by this paper
• Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial.

  1999cited by this paper
• The pathogenesis and treatment of pruritus and fatigue in patients with PBC.

  1999cited by this paper
• Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial.

  1999cited by this paper
• Anti-mitochondrial antibodies and other immunological tests in primary biliary cirrhosis.

  1999cited by this paper
• Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis.

  1999cited by this paper
• Ten‐year survival in ursodeoxycholic acid–treated patients with primary biliary cirrhosis

  1999cited by this paper
• Identification of major linear epitopes on the sp100 nuclear PBC autoantigen by the gene-fragment phage-display technology.

  1999cited by this paper
• Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study.

  1998cited by this paper
• Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Clinical features and response to therapy

  1998cited by this paper
• Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.

  1997cited by this paper
• Nuclear envelope protein autoantibodies in primary biliary cirrhosis.

  1997cited by this paper
• Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study.

  1996cited by this paper
• Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.

  1996cited by this paper
• Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis.

  1996cited by this paper
• Combined treatment with methotrexate and ursodeoxycholic acid in non-cirrhotic primary biliary cirrhosis.

  1996cited by this paper
• A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.

  1996cited by this paper
• Specificity and sensitivity of gp210 autoantibodies detected using an enzyme‐linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis

  1996cited by this paper
• Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome

  1995cited by this paper
• Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?

  1994cited by this paper
• Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial.

  1993cited by this paper
• A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results.

  1992cited by this paper
• [Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study].

  1992cited by this paper
• Primary biliary cirrhosis: paradigm or paradox for autoimmunity.

  1991cited by this paper
• A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis.

  1990cited by this paper
• Evaluation of colchicine therapy in primary biliary cirrhosis.

  1988cited by this paper
• A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report.

  1987cited by this paper
• [A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis)].

  1987cited by this paper
• A prospective trial of colchicine for primary biliary cirrhosis.

  1986cited by this paper
• Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial.

  1985cited by this paper
• Trial of penicillamine in advanced primary biliary cirrhosis.

  1985cited by this paper
• D-penicillamine for primary biliary cirrhosis.

  1985cited by this paper
• A prospective clinical trial of D‐penicillamine in the treatment of primary biliary cirrhosis

  1985cited by this paper
• Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.

  1985cited by this paper
• A prospective trial of D-penicillamine in primary biliary cirrhosis.

  1982cited by this paper
• Serum bilirubin: a prognostic factor in primary biliary cirrhosis.

  1979cited by this paper
• A prospective controlled trial of azathioprine in primary biliary cirrhosis.

  1976cited by this paper

• Moderne Therapie der primär biliären Cholangitis

  2017cites this paper
• Folgeerkrankungen nach Organtransplantation

  2006cites this paper
• [Sequelae of organ transplantation].

  2006cites this paper
• Lebertransplantation zwischen Indikation und Spenderallokation

  2004cites this paper
• [Liver transplantation: deciding between need and donor allocation].

  2004cites this paper